Investigating a novel method to predict weight outcome after a weight loss program

Completed

• Conditions: obesity; Diet and Nutrition - Obesity; Metabolic and Endocrine - Normal metabolism and endocrine development and function

• Registration Number: ACTRN12614000197639
• Lead Sponsor: niversity of Melbourne, Department of Medicine (Austin Health)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-02-24
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Weight stable for 3 months
BMI greater than/equal to 30kg/m2 or BMI greater than/equal to 27kg/m2 with a medical condition related to excess weight
BMI less than 60kg/m2

Exclusion Criteria

Pregnancy or breast-feeding
Previous surgery for weight loss
The use of a VLED or weight-lowering medication in the past 3 months
Change in weight of 3kg or more in the past 3 months
Change in dosage of thyroid or other hormone replacement in past 3 months
Planned surgery during the study
Cessation of smoking in past 6 months
Uncontrolled or clinically significant disease which would be a contraindication to a VLED
Known alcohol or drug dependence in past 1 year

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prediction of weight outcome following VLED using a linear discriminant analysis (LDA) model[12 months after weight loss];Re-evaluation of the predictive accuracy of the LDA model after incorporation of data regarding biological and psychosocial factors (obtained via anthropometric measurements, biochemical testing and questionnaires). [12 months after weight loss]

Secondary Outcome Measures

Name	Time	Method
nil[N/A]